Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Statistical physics of fracture and earthquakes.

Biswas S, Goehring L, Chakrabarti BK.

Philos Trans A Math Phys Eng Sci. 2018 Nov 26;377(2136). pii: 20180202. doi: 10.1098/rsta.2018.0202.

2.

Hydrodynamic descriptions for surface roughness in fracture front propagation.

Basu A, Chakrabarti BK.

Philos Trans A Math Phys Eng Sci. 2018 Nov 26;377(2136). pii: 20170387. doi: 10.1098/rsta.2017.0387.

PMID:
30478199
3.

Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail.

Samal S, Das S, Boliar S, Qureshi H, Shrivastava T, Kumar N, Goswami S, Bansal M, Chakrabarti BK.

Retrovirology. 2018 Jul 20;15(1):50. doi: 10.1186/s12977-018-0431-4.

4.

Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.

Boliar S, Patil S, Shukla BN, Ghobbeh A, Deshpande S, Chen W, Guenaga J, Dimitrov DS, Wyatt RT, Chakrabarti BK.

Virology. 2018 Jun;519:99-105. doi: 10.1016/j.virol.2018.04.002. Epub 2018 May 11.

5.

Possible ergodic-nonergodic regions in the quantum Sherrington-Kirkpatrick spin glass model and quantum annealing.

Mukherjee S, Rajak A, Chakrabarti BK.

Phys Rev E. 2018 Feb;97(2-1):022146. doi: 10.1103/PhysRevE.97.022146.

PMID:
29548183
6.

Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.

Shrivastava T, Samal S, Tyagi AK, Goswami S, Kumar N, Ozorowski G, Ward AB, Chakrabarti BK.

Vaccine. 2018 Mar 14;36(12):1627-1636. doi: 10.1016/j.vaccine.2018.01.081. Epub 2018 Feb 9.

PMID:
29429810
7.

Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505.

Das S, Boliar S, Samal S, Ahmed S, Shrivastava T, Shukla BN, Goswami S, Bansal M, Chakrabarti BK.

Virology. 2017 Oct;510:22-28. doi: 10.1016/j.virol.2017.07.001. Epub 2017 Jul 6.

8.

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein.

Ahmed S, Shrivastava T, Kumar N, Ozorowski G, Ward AB, Chakrabarti BK.

J Biol Chem. 2017 May 19;292(20):8236-8243. doi: 10.1074/jbc.M117.776419. Epub 2017 Mar 10.

10.

Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies.

Deshpande S, Patil S, Kumar R, Shrivastava T, Srikrishnan AK, Murugavel KG, Koff WC, Chakrabarti BK, Bhattacharya J.

Retrovirology. 2016 Jun 15;13(1):41. doi: 10.1186/s12977-016-0273-x.

11.

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.

Mason RD, Welles HC, Adams C, Chakrabarti BK, Gorman J, Zhou T, Nguyen R, O'Dell S, Lusvarghi S, Bewley CA, Li H, Shaw GM, Sheng Z, Shapiro L, Wyatt R, Kwong PD, Mascola JR, Roederer M.

PLoS Pathog. 2016 May 24;12(5):e1005674. doi: 10.1371/journal.ppat.1005674. eCollection 2016 May.

12.

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.

Mason RD, Welles HC, Adams C, Chakrabarti BK, Gorman J, Zhou T, Nguyen R, O'Dell S, Lusvarghi S, Bewley CA, Li H, Shaw GM, Sheng Z, Shapiro L, Wyatt R, Kwong PD, Mascola JR, Roederer M.

PLoS Pathog. 2016 Apr 11;12(4):e1005537. doi: 10.1371/journal.ppat.1005537. eCollection 2016 Apr. Erratum in: PLoS Pathog. 2016 May;12(5):e1005674.

13.

Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.

Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J.

J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.

14.

Universality of Citation Distributions for Academic Institutions and Journals.

Chatterjee A, Ghosh A, Chakrabarti BK.

PLoS One. 2016 Jan 11;11(1):e0146762. doi: 10.1371/journal.pone.0146762. eCollection 2016. Erratum in: PLoS One. 2016;11(2):e0148863.

15.

Classical-to-quantum crossover in the critical behavior of the transverse-field Sherrington-Kirkpatrick spin glass model.

Mukherjee S, Rajak A, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 Oct;92(4):042107. doi: 10.1103/PhysRevE.92.042107. Epub 2015 Oct 5.

PMID:
26565168
16.

An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies.

Boliar S, Das S, Bansal M, Shukla BN, Patil S, Shrivastava T, Samal S, Goswami S, King CR, Bhattacharya J, Chakrabarti BK.

PLoS One. 2015 Mar 30;10(3):e0122443. doi: 10.1371/journal.pone.0122443. eCollection 2015.

17.

Zipf's law in city size from a resource utilization model.

Ghosh A, Chatterjee A, Chakrabarti AS, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Oct;90(4):042815. Epub 2014 Oct 27.

PMID:
25375557
18.

Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner.

Patil S, Choudhary I, Chaudhary NK, Ringe R, Bansal M, Shukla BN, Boliar S, Chakrabarti BK, Bhattacharya J.

Virology. 2014 Aug;462-463:266-72. doi: 10.1016/j.virol.2014.06.018. Epub 2014 Jul 5.

19.

Self-organized dynamics in local load-sharing fiber bundle models.

Biswas S, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Oct;88(4):042112. Epub 2013 Oct 7.

PMID:
24229121
20.

Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.

Chakrabarti BK, Feng Y, Sharma SK, McKee K, Karlsson Hedestam GB, Labranche CC, Montefiori DC, Mascola JR, Wyatt RT.

J Virol. 2013 Dec;87(24):13239-51. doi: 10.1128/JVI.01247-13. Epub 2013 Sep 25. Erratum in: J Virol. 2015 Jan;89(1):887.

21.

Noise-induced rupture process: phase boundary and scaling of waiting time distribution.

Pradhan S, Chandra AK, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jul;88(1):012123. Epub 2013 Jul 18.

PMID:
23944430
22.

Anti-HIV B Cell lines as candidate vaccine biosensors.

Ota T, Doyle-Cooper C, Cooper AB, Huber M, Falkowska E, Doores KJ, Hangartner L, Le K, Sok D, Jardine J, Lifson J, Wu X, Mascola JR, Poignard P, Binley JM, Chakrabarti BK, Schief WR, Wyatt RT, Burton DR, Nemazee D.

J Immunol. 2012 Nov 15;189(10):4816-24. doi: 10.4049/jimmunol.1202165. Epub 2012 Oct 12.

23.

HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins.

Li Y, O'Dell S, Wilson R, Wu X, Schmidt SD, Hogerkorp CM, Louder MK, Longo NS, Poulsen C, Guenaga J, Chakrabarti BK, Doria-Rose N, Roederer M, Connors M, Mascola JR, Wyatt RT.

J Virol. 2012 Oct;86(20):11231-41. Epub 2012 Aug 8.

24.

Continuous transition of social efficiencies in the stochastic-strategy minority game.

Biswas S, Ghosh A, Chatterjee A, Naskar T, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Mar;85(3 Pt 1):031104. Epub 2012 Mar 2.

PMID:
22587035
25.

Phase transitions in crowd dynamics of resource allocation.

Ghosh A, De Martino D, Chatterjee A, Marsili M, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Feb;85(2 Pt 1):021116. Epub 2012 Feb 10.

PMID:
22463162
26.

Threshold-induced phase transition in kinetic exchange models.

Ghosh A, Basu U, Chakraborti A, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Jun;83(6 Pt 1):061130. Epub 2011 Jun 20.

PMID:
21797325
27.

Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity.

Chakrabarti BK, Walker LM, Guenaga JF, Ghobbeh A, Poignard P, Burton DR, Wyatt RT.

J Virol. 2011 Aug;85(16):8217-26. doi: 10.1128/JVI.00756-11. Epub 2011 Jun 8.

28.

Opinion formation in kinetic exchange models: spontaneous symmetry-breaking transition.

Lallouache M, Chakrabarti AS, Chakraborti A, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Nov;82(5 Pt 2):056112. Epub 2010 Nov 16.

PMID:
21230550
29.

Effect of fractal disorder on static friction in the Tomlinson model.

Eriksen JA, Biswas S, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4 Pt 1):041124. Epub 2010 Oct 26. Erratum in: Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4 Pt 2):049905.

PMID:
21230255
30.

HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.

Chakrabarti BK, Pancera M, Phogat S, O'Dell S, McKee K, Guenaga J, Robinson J, Mascola J, Wyatt RT.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19.

31.

Quantum phase transition in a disordered long-range transverse Ising antiferromagnet.

Chandra AK, Inoue J, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Feb;81(2 Pt 1):021101. Epub 2010 Feb 1.

PMID:
20365524
32.

Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site.

Dey B, Svehla K, Xu L, Wycuff D, Zhou T, Voss G, Phogat A, Chakrabarti BK, Li Y, Shaw G, Kwong PD, Nabel GJ, Mascola JR, Wyatt RT.

PLoS Pathog. 2009 May;5(5):e1000445. doi: 10.1371/journal.ppat.1000445. Epub 2009 May 29.

33.

Reaching the ground state of a quantum spin glass using a zero-temperature quantum Monte Carlo method.

Das A, Chakrabarti BK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Dec;78(6 Pt 1):061121. Epub 2008 Dec 19.

PMID:
19256816
34.

Neural network modeling.

Chakrabarti BK, Basu A.

Prog Brain Res. 2008;168:155-68. doi: 10.1016/S0079-6123(07)68013-3. Review.

PMID:
18166393
35.

Gestational trophoblastic tumor at a tertiary level cancer center: a retrospective study.

Chakrabarti BK, Mondal NR, Chatterjee T.

J Reprod Med. 2006 Nov;51(11):875-8.

PMID:
17165433
36.

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.

Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, Andrews CA, Gomez PL, Mascola JR, Nabel GJ; Vaccine Research Center 004 Study Team.

J Infect Dis. 2006 Dec 15;194(12):1650-60. Epub 2006 Nov 8.

37.

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS; Vaccine Research Center 006 Study Team.

J Infect Dis. 2006 Dec 15;194(12):1638-49. Epub 2006 Nov 8. Erratum in: J Infect Dis. 2009 Oct 15;200(8):1352-3.

38.

Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2.

Kim JO, Chakrabarti BK, Guha-Niyogi A, Louder MK, Mascola JR, Ganesh L, Nabel GJ.

J Virol. 2007 Feb;81(3):1444-50. Epub 2006 Nov 8.

39.

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial.

Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, Graham BS.

Clin Vaccine Immunol. 2006 Nov;13(11):1267-77. Epub 2006 Sep 20.

40.

Quantum annealing in a kinetically constrained system.

Das A, Chakrabarti BK, Stinchcombe RB.

Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Aug;72(2 Pt 2):026701. Epub 2005 Aug 1.

PMID:
16196745
41.

Master equation for a kinetic model of a trading market and its analytic solution.

Chatterjee A, Chakrabarti BK, Stinchcombe RB.

Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Aug;72(2 Pt 2):026126. Epub 2005 Aug 22.

PMID:
16196663
42.

Crossover behavior in a mixed-mode fiber bundle model.

Pradhan S, Chakrabarti BK, Hansen A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Mar;71(3 Pt 2A):036149. Epub 2005 Mar 29.

PMID:
15903535
43.

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates.

Santra S, Seaman MS, Xu L, Barouch DH, Lord CI, Lifton MA, Gorgone DA, Beaudry KR, Svehla K, Welcher B, Chakrabarti BK, Huang Y, Yang ZY, Mascola JR, Nabel GJ, Letvin NL.

J Virol. 2005 May;79(10):6516-22.

44.

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate.

Chakrabarti BK, Ling X, Yang ZY, Montefiori DC, Panet A, Kong WP, Welcher B, Louder MK, Mascola JR, Nabel GJ.

Vaccine. 2005 May 16;23(26):3434-45.

PMID:
15837367
45.

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.

Seaman MS, Xu L, Beaudry K, Martin KL, Beddall MH, Miura A, Sambor A, Chakrabarti BK, Huang Y, Bailer R, Koup RA, Mascola JR, Nabel GJ, Letvin NL.

J Virol. 2005 Mar;79(5):2956-63.

46.

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.

Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL.

J Virol. 2005 Jan;79(2):771-9.

47.

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.

Letvin NL, Huang Y, Chakrabarti BK, Xu L, Seaman MS, Beaudry K, Korioth-Schmitz B, Yu F, Rohne D, Martin KL, Miura A, Kong WP, Yang ZY, Gelman RS, Golubeva OG, Montefiori DC, Mascola JR, Nabel GJ.

J Virol. 2004 Jul;78(14):7490-7.

48.

Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope.

Yang ZY, Chakrabarti BK, Xu L, Welcher B, Kong WP, Leung K, Panet A, Mascola JR, Nabel GJ.

J Virol. 2004 Apr;78(8):4029-36. Erratum in: J Virol. 2006 Apr;80(8):4206.

49.

Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.

Kong WP, Huang Y, Yang ZY, Chakrabarti BK, Moodie Z, Nabel GJ.

J Virol. 2003 Dec;77(23):12764-72.

50.

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Lemiale F, Kong WP, Aky├╝rek LM, Ling X, Huang Y, Chakrabarti BK, Eckhaus M, Nabel GJ.

J Virol. 2003 Sep;77(18):10078-87.

Supplemental Content

Loading ...
Support Center